San Francisco, CA - endpoint, an interactive response technology (IRT) solutions provider, introduces its new clinical supply management tool DRIVE, which enables IRT functionality for non-IRT and Investigator-Sponsored Trials (IIT). DRIVE will be unveiled at the Drug Information Association (DIA) Annual Meeting, June 26-30, in Philadelphia. DRIVE delivers the benefits of IRT supplies management to the entire development program, including early-phase non-IRT and IIT, in one system - saving sponsors and sites time, reducing waste and optimizing the supply chain. Features include:
“While individual, stand-alone IRT systems for patient and supplies management are not warranted for every study, the challenge of managing supplies across IRT and non-IRT studies, including IIT, remains a sponsor pain point. To alleviate this issue, endpoint has developed DRIVE, a dynamic, easy-to-use clinical supply management hub,” said Chuck Harris, general manager. “DRIVE reflects endpoint’s commitment to addressing our industry’s challenges with novel, SaaS-based solutions.” endpoint will also be unveiling its new brand, which showcases endpoint’s services and technology by both highlighting the company’s proven expertise and emphasizing PULSE as a reliable IRT solution. Stop by Booth 501 at DIA or
schedule a meeting
to ask about endpoint’s feature-rich supply chain and clinical management tools and see how it gets
Straight to the Point
.
About endpoint
endpoint is focused primarily on providing interactive response technology (IRT) systems and solutions that support the life sciences industry. endpoint’s proprietary IRT system configuration engine, PULSE, provides non-technical users with the necessary tools to design and deploy customized IRT solutions in just four weeks. Having a team with up to 20 years of industry experience and headquartered in San Francisco, endpoint has been developing IRT systems since 2009. See how our flexible IRT solution meets the unique needs of any clinical trial at
www.endpointclinical.com
.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.